Last: | $11.10 |
---|---|
Change Percent: | -13.42% |
Open: | $12.59 |
Close: | $11.10 |
High: | $12.59 |
Low: | $11.1 |
Volume: | 3,753 |
Last Trade Date Time: | 03/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.1 | $12.59 | $11.1 | $12.59 | $11.1 | 3,753 | 03-26-2024 |
$12.6 | $12.528 | $12.6 | $13.37 | $12.1738 | 4,414 | 03-25-2024 |
$13.03 | $13.54 | $13.03 | $13.8996 | $13.03 | 2,982 | 03-22-2024 |
$13.29 | $13 | $13.29 | $14 | $13 | 8,499 | 03-21-2024 |
$13.01 | $15.9 | $13.01 | $15.9 | $12.585 | 21,150 | 03-20-2024 |
$14.53 | $15.4 | $14.53 | $16.01 | $13.52 | 16,037 | 03-19-2024 |
$16.9022 | $21.99 | $16.9022 | $21.99 | $15.15 | 23,467 | 03-18-2024 |
$22.32 | $15.0001 | $22.32 | $22.32 | $11.5127 | 24,850 | 03-15-2024 |
$0.51 | $0.45 | $0.51 | $0.5999 | $0.430001 | 566,036 | 03-14-2024 |
$0.42 | $0.46 | $0.42 | $0.649 | $0.42 | 1,407,941 | 03-13-2024 |
$0.4545 | $0.34 | $0.4545 | $0.4574 | $0.34 | 362,472 | 03-12-2024 |
$0.348 | $0.3581 | $0.348 | $0.3781 | $0.3401 | 102,792 | 03-11-2024 |
$0.38 | $0.384899 | $0.38 | $0.39 | $0.3674 | 38,380 | 03-08-2024 |
$0.38 | $0.38 | $0.38 | $0.39 | $0.360001 | 60,604 | 03-07-2024 |
$0.39 | $0.3879 | $0.39 | $0.3902 | $0.37 | 11,161 | 03-06-2024 |
$0.392 | $0.39 | $0.392 | $0.3975 | $0.374 | 16,480 | 03-05-2024 |
$0.3925 | $0.36 | $0.3925 | $0.3975 | $0.355 | 77,251 | 03-04-2024 |
$0.37 | $0.3885 | $0.37 | $0.395 | $0.37 | 20,906 | 03-01-2024 |
$0.381 | $0.3711 | $0.381 | $0.399 | $0.361 | 52,440 | 02-29-2024 |
$0.371 | $0.3894 | $0.371 | $0.3895 | $0.36 | 34,836 | 02-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...